Potential of adult neural stem cells in stroke therapy

Regenerative Medicine

Volumn 3, Issue 6, 2008, Pages 893-905

  Andres, Robert H ^a   Choi, Raymond ^a   Steinberg, Gary K ^a   Guzman, Raphael ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult neural stem cells; Intravascular transplantation; Neural transplantation; Neurogenesis; Regenerative medicine; Stroke

Indexed keywords

ALPHA1 INTEGRIN; ALPHA6 INTEGRIN; ANGIOPOIETIN 1; BETA INTEGRIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NOTCH RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR SOX1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; WNT PROTEIN;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL STIMULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; HUMAN; IMMUNOMODULATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SUBVENTRICULAR ZONE; TREATMENT RESPONSE;

ADULT STEM CELLS; ANIMALS; HUMANS; NEURONS; STEM CELL TRANSPLANTATION; STROKE;

EID: 58149122759     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.3.6.893     Document Type: Review

References (106)

1. Modan B, Wagener DK: Some epidemiological aspects of stroke: mortality/ morbidity trends, age, sex, race, socioeconomic status. Stroke 23(9), 1230-1236 (1992).
2. Eriksson M, Norrving B, Terent A, Stegmayr B: Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc. Dis. 25(5), 423-429 (2008).
3. Marler JR, Brott T, Broderick J et al.: Tissue-plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333(24), 1581-1587 (1995).
4. Bliss T, Guzman R, Daadi M, Steinberg GK: Cell transplantation therapy for stroke. Stroke 38(Suppl. 2), 817-826 (2007).
5. Andres RH, Guzman R, Ducray AD et al.: Cell replacement therapy for intracerebral hemorrhage. Neurosurg. Focus 24(3-4), E16 (2008).
6. Kondziolka D, Wechsler L, Goldstein S et al.: Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55(4), 565-569 (2000).
7. Kondziolka D, Steinberg GK, Wechsler L et al.: Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J. Neurosurg. 103(1), 38-45 (2005).
8. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis. 20(2), 101-107 (2005).
9. Bang OY, Lee JS, Lee PH, Lee G: Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57(6), 874-882 (2005).
10. Pierret C, Spears K, Maruniak JA, Kirk MD: Neural crest as the source of adult stem cells. Stem Cells Dev. 15(2), 286-291 (2006).
11. Clarke D, Frisen J: Differentiation potential of adult stem cells. Curr. Opin. Genet. Dev. 11(5), 575-580 (2001).
12. Cogle CR, Yachnis AT, Laywell ED et al.: Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 363(9419), 1432-1437 (2004).
13. Seaberg RM, Smukler SR, Kieffer TJ et al.: Clonal identification of multipotentprecursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22(9), 1115-1124 (2004).
14. Joannides A, Gaughwin P, Schwiening C et al.: Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells. Lancet 364(9429), 172-178 (2004).
15. Tang YM, Yasuhara T, Hara K et al.: Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant. 16(2), 159-169 (2007).
16. Jung KH, Chu K, Lee ST et al.: Identification of neuronal outgrowth cells from peripheral blood of stroke patients. Ann. Neurol. 63(3), 312-322 (2008).
17. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006).
18. Park IH, Zhao R, West JA et al.: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175), 141-146 (2008).
19. Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
20. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007).
21. Zhao C, Deng W, Gage FH: Mechanisms and functional implications of adult neurogenesis. Cell 132(4), 645-660 (2008).
22. Alvarez-Buylla A, Lim DA: For the long run: maintaining germinal niches in the adult brain. Neuron 41(5), 683-686 (2004).
23. Eriksson PS, Perfilieva E, Bjork-Eriksson T et al.: Neurogenesis in the adult human hippocampus. Nat. Med. 4(11), 1313-1317 (1998).
24. McKay R: Stem cells in the central nervous system. Science 276(5309), 66-71 (1997).
25. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH: Functional neurogenesis in the adult-hippocampus. Nature 415(6875), 1030-1034 (2002).
26. Palmer TD, Markakis EA, Willhoire AR, Safar F, Gage FH: Fibroblast growth factor 2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci. 19(19), 8487-8497 (1999).
27. Palmer TD, Ray J, Gage FH: Fgf2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol. Cell. Neurosci. 6(5), 474-486 (1995).
28. Bhardwaj RD, Curtis MA, Spalding KL et al.: Neocortical neurogenesis in humans is restricted to development. Proc. Natl Acad. Sci. USA 103(33), 12564-12568 (2006).
29. Rakic P: Neuroscience. No more cortical neurons for you. Science 313(5789), 928-929 (2006).
30. Lie DC, Colamarino SA, Song HJ et al.: Wnt signalling regulates adult hippocampal neurogenesis. Nature 437(7063), 1370-1375 (2005).
31. Gustafsson E, Andsberg G, Darsalia V et al.: Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke. Eur. J. Neurosci. 17(12), 2667-2678 (2003).
32. Kobayashi T, Ahlenius H, Thored P, Kobayashi R, Kokaia Z, Lindvall O: Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 37(9), 2361-2367 (2006).
33. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA: Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl Acad. Sci. USA 99(18), 11946-11950 (2002).
34. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH: Epidermal growth factor and fibroblast growth factor2 have different effects on neural progenitors in the adult rat brain. J. Neurosci. 17(15), 5820-5829 (1997).
35. Shingo T, Sorokan ST, Shimazaki T, Weiss S: Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21(24), 9733-9743 (2001).
36. Jagasia R, Song H, Gage FH, Lie DC: New regulators in adult neurogenesis and their potential role for repair. Trends Mol. Med. 12(9), 400-405 (2006).
37. Darsalia V, Heldmann U, Lindvall O, Kokaia Z: Stroke-induced neurogenesis in aged brain. Stroke 36(8), 1790-1795 (2005).
38. Zhu LL, Zhao T, Li HS et al.: Neurogenesis in the adult rat brain after intermittent hypoxia. Brain Res. 1055(1-2), 1-6 (2005).
39. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8(9), 963-970 (2002).
40. Liu J, Solway K, Messing RO, Sharp FR: Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18(19), 7768-7778 (1998).
41. Arvidsson A, Kokaia Z, Lindvall O: N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur. J. Neurosci. 14(1), 10-18 (2001).
42. Jin K, Minami M, Lan JQ et al.: Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl Acad. Sci. USA 98(8), 4710-4715 (2001).
43. Okano H, Sakaguchi M, Ohki K, Suzuki N, Sawamoto K: Regeneration of the central nervous system using endogenous repair mechanisms. J. Neurochem. 102(5), 1459-1465 (2007).
44. Hoehn BD, Palmer TD, Steinberg GK: Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 36(12), 2718-2724 (2005).
45. Ohab JJ, Fleming S, Blesch A, Carmichael ST: A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26(50), 13007-13016 (2006).
46. Thored P, Arvidsson A, Cacci E et al.: Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24(3), 739-747 (2005).
47. Imitola J, Raddassi K, Park KI et al.: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1a/CXC chemokine receptor4 pathway. Proc. Natl Acad. Sci. USA 101(52), 18117-18122 (2004).
48. Yan YP, Sailor KA, Lang BT, Park SW, Vemuganti R, Dempsey RJ: Monocyte chemoattractant protein 1 plays a critical role in neuroblast migration after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 27(6), 1213-1224 (2007).
49. Sawamoto K, Wichterle H, Gonzalez-Perez O et al.: New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 311(5761), 629-632 (2006).
50. Lee SR, Kim HY, Rogowska J et al.: Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci. 26(13), 3491-3495 (2006).
51. Jin K, Wang X, Xie L et al.: Evidence for stroke-induced neurogenesis in the human brain. Proc. Natl Acad. Sci. USA 103(35), 13198-13202 (2006).
52. Wright LS, Li J, Caldwell MA, Wallace K, Johnson JA, Svendsen CN: Gene expression in human neural stem cells: effects of leukemia inhibitory factor. J. Neurochem. 86(1), 179-195 (2003).
53. Keyoung HM, Roy NS, Benraiss A et al.: High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. Nat. Biotechnol. 19(9), 843-850 (2001).
54. Sonntag KC, Simantov R, Isacson O: Stem cells may reshape the prospect of Parkinson's disease therapy. Brain Res. Mol. Brain Res. 134(1), 34-51 (2005).
55. Andres RH, Meyer M, Ducray AD, Widmer HR: Restorative neuroscience: concepts and perspectives. Swiss Med. Wkly 138(11-12), 155-172 (2008).
56. Andres RH, Ducray AD, Huber AW et al.: Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. J. Neurochem. 95(1), 33-45 (2005).
57. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290(5497), 1779-1782 (2000).
58. Brazelton TR, Rossi FM, Keshet GI, Blau HM: From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290(5497), 1775-1779 (2000).
59. Sanchez-Ramos JR, Song S, Kamath SG et al.: Expression of neural markers in human umbilical cord blood. Exp. Neurol. 171(1), 109-115 (2001).
60. Chen J, Sanberg PR, Li Y et al.: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32(11), 2682-2688 (2001).
61. Nan Z, Grande A, Sanberg CD, Sanberg PR, Low WC: Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann. NY Acad. Sci. 1049, 84-96 (2005).
62. Kim JM, Lee ST, Chu K et al.: Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 1183, 43-50 (2007).
63. Andrews PW, Damjanov I, Simon D et al.: Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera2. Differentiation in vivo and in vitro. Lab. Invest. 50(2), 147-162 (1984).
64. Kleppner SR, Robinson KA, Trojanowski JQ, Lee VM: Transplanted human neurons derived from a teratocarcinoma cell line (NTera2) mature, integrate, and survive for over 1 year in the nude mouse brain. J. Comp. Neurol. 357(4), 618-632 (1995).
65. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR: Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp. Neurol. 149(2), 310-321 (1998).
66. Toda H, Takahashi J, Iwakami N et al.: Grafting neural stem cells improved the impaired spatial recognition in ischemic rats. Neurosci. Lett. 316(1), 9-12 (2001).
67. Zhang ZG, Jiang Q, Zhang R et al.: Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann. Neurol. 53(2), 259-263 (2003).
68. Jiang Q, Zhang ZG, Ding GL et al.: Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage 28(3), 698-707 (2005).
69. Li L, Jiang Q, Zhang L et al.: Ischemic cerebral tissue response to subventricular zone cell transplantation measured by iterative self-organizing data analysis technique algorithm. J. Cereb. Blood Flow Metab. 26(11), 1366-1377 (2006).
70. Kameda M, Shingo T, Takahashi K et al.: Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur. J. Neurosci. 26(6), 1462-1478 (2007).
71. Hicks AU, Hewlett K, Windle V et al.: Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke. Neuroscience 146(1), 31-40 (2007).
72. Kim DE, Schellingerhout D, Ishii K, Shah K, Weissleder R: Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke 35(4), 952-957 (2004).
73. Guzman R, Bliss T, De Los Angeles A, Moseley M, Palmer T, Steinberg G: Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset. J. Neurosci. Res. 86(4), 873-882 (2008).
74. Guzman R, Los Angeles A, Cheshier S et al.: Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 39(4), 1300-1306 (2008).
75. Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM: Stem cells. Lancet 366(9485), 592-602 (2005).
76. Schiff LJ: Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products. In Vitro Cell. Dev. Biol. Anim. 41(3-4), 65-70 (2005).
77. Martin MJ, Muotri A, Gage F, Varki A: Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11(2), 228-232 (2005).
78. Grompe M: Adult versus embryonic stem cells: it's still a tie. Mol. Ther. 6(3), 303-305 (2002).
79. Guzman R, Choi R, Gera A, De Los AA, Andres RH, Steinberg GK: Intravascular cell replacement therapy for stroke. Neurosurg. Focus 24(3-4), E15 (2008).
80. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (9), 391-397 (1999).
81. Pluchino S, Quattrini A, Brambilla E et al.: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422(6933), 688-694 (2003).
82. Pluchino S, Zanotti L, Rossi B et al.: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436(7048), 266-271 (2005).
83. Mueller FJ, Serobyan N, Schraufstatter IU et al.: Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells 24(11), 2367-2372 (2006).
84. Guzman R, Uchida N, Bliss TM et al.: Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc. Natl Acad. Sci. USA 104(24), 10211-10216 (2007).
85. Walczak P, Zhang J, Gilad AA et al.: Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39(5), 1569-1574 (2008).
86. Englund U, Bjorklund A, Wictorin K, Lindvall O, Kokaia M: Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc. Natl Acad. Sci. USA 99(26), 17089-17094 (2002).
87. Wernig M, Benninger F, Schmandt T et al.: Functional integration of embryonic stem cell-derived neurons in vivo. J. Neurosci. 24(22), 5258-5268 (2004).
88. Dunnett SB: Functional repair of striatal systems by neural transplants: evidence for circuit reconstruction. Behav. Brain Res. 66(1-2), 133-142 (1995).
89. Sorensen AT, Thompson L, Kirik D, Bjorklund A, Lindvall O, Kokaia M: Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts. Eur. J. Neurosci. 21(10), 2793-2799 (2005).
90. Nakao N, Itakura T: Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. Prog. Neurobiol. 61(3). 313-338 (2000).
91. Vendrame M, Cassady J, Newcomb J et al.: Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35(10), 2390-2395 (2004).
92. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR: Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35(10), 2385-2389 (2004).
93. Schaller B, Andres RH, Huber AW et al.: Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons. Brain Res. 1036(1-2), 163-172 (2005).
94. Chopp M, Zhang ZG, Jiang Q: Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 38(Suppl. 2), 827-831 (2007).
95. Liauw J, Hoang S, Choi M et al.: Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J. Cereb. Blood Flow Metab. 28(10), 1722-1732 (2008).
96. Pluchino S, Martino G: Neural stem cell-mediated immunomodulation: repairing the haemorrhagic brain. Brain 131(Pt 3), 604-605 (2008).
97. Hess DC, Borlongan CV: Stem cells and neurological diseases. Cell Prolif. 41, 94-114 (2008).
98. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD: IV infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136(1), 161-169 (2005).
99. Muraoka K, Shingo T, Yasuhara T et al.: The high integration and differentiation potential of autologous neural stem cell transplantation compared with allogeneic transplantation in adult rat hippocampus. Exp. Neurol. 199(2), 311-327 (2006).
100. Agarwal S, Lensch MW, Daley GQ: Current prospects for the generation of patient-specific pluripotent cells from adult tissues. Regen. Med. 2(5), 743-752 (2007).
101. Leker RR, McKay RD: Using endogenous neural stem cells to enhance recovery from ischemic brain injury. Curr. Neurovasc. Res. 1(5), 421-427 (2004).
102. Sohur US, Emsley JG, Mitchell BD, Macklis JD: Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361(1473), 1477-1497 (2006).
103. Abrahams JM, Gokhan S, Flamm ES, Mehler MF: De novo neurogenesis and acute stroke: are exogenous stem cells really necessary? Neurosurgery 54(1), 150-155 (2004).
104. Emsley JG, Mitchell BD, Kempermann G, Macklis JD: Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog. Neurobiol. 75(5), 321-341 (2005).
105. Tureyen K, Vemuganti R, Bowen KK, Sailor KA, Dempsey RJ: EGF and FGF2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain. Neurosurgery 57(6), 1254-1263 (2005).
106. Takahashi J, Palmer TD, Gage FH: Retinoic acid and neurotrophins collaborate to regulate neurogenesis. In adult-derived neural stem cell cultures. J. Neurobiol. 38(1), 65-81 (1999).